Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
about
The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosisInhibition of gelatinase activity in human airway epithelial cells and fibroblasts by dexamethasone and beclomethasoneIn vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivoOverexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patientsIncreased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinomaSynergy between a plasminogen cascade and MMP-9 in autoimmune diseaseProtein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9Myocardial matrix metalloproteinase-2: inside out and upside down.Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoidMembrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancerMatrix-metalloproteinase-9 is cleaved and activated by cathepsin K.Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumorsRequirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinomaDifferential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.Fibronectin Deposition Participates in Extracellular Matrix Assembly and Vascular Morphogenesis.Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancerMMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expressionMatrix metalloproteases: underutilized targets for drug deliveryNovel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins.Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway.Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring.Cystatin superfamily.Lp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment.Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasisTitanium particles up-regulate the activity of matrix metalloproteinase-2 in human synovial cells.Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis.Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
P2860
Q27009126-ABDFBC5D-C5DD-47EE-9AB9-BEF1BA401DEFQ28343521-F18BC18C-4B1D-4EAF-BD4E-A266375C543FQ28345259-912BDDFE-3E1D-4B8A-A6C7-CA7EA70221D2Q28366039-919EF2D7-5B39-43B2-BAEF-7638E5B38030Q33599264-C6DAA11E-4369-4EF6-A542-8C5B9D75C6C2Q33726930-470CDAAE-C46A-49CB-9414-867601D7265FQ34049288-1E8915A8-D903-443A-A171-AFF5A363D419Q34252516-FFDD7268-3A6E-4212-932F-56C8C4E00A60Q34906086-626231A3-CECB-44CB-9830-B2E2B9AAF774Q35032465-C946F004-25B9-4485-8710-796AE3FC8579Q35083825-EC80A88F-0DD6-4CEE-9377-B51DF023EE9DQ35423717-E444AD3D-27B1-4A8E-9D29-DC23EFC07A47Q35586223-EB6CB330-A087-4C66-A29E-99D2AEAF8B08Q35720752-42FAF7BA-94DD-4ACE-8F0F-8D7629EF1670Q35745943-CED29067-8461-4C16-9921-51EEC97C6CABQ35753243-826B5598-4757-46AD-8C24-DE6F30BB27D6Q35763791-24D86C42-B0A0-4E0E-BC6A-2B6BD384CC44Q35765041-ACBCBC2A-A6E7-41AA-BDA2-BB7E626EA333Q35773709-9169EAC8-D144-4455-81CF-5C4B3DA9389EQ35904797-B0AA0A43-55B3-4117-B3E0-2D7C583518BAQ36115177-0228761A-0A6F-4BE8-B9A1-6B92609A3333Q36366058-21255F9C-57B2-4A43-BE28-FEB5A3F849ABQ36761849-61353CD0-F82C-499F-9DCD-07E0ADEF1744Q36840365-63448B8C-E283-400B-B44D-ACD352B1E80BQ36845792-ACC6EEDA-9B6E-40E4-AAB5-C3898576AE3CQ37118844-01B8F5E4-1B11-4A55-84D8-1EA244D60D59Q37375269-DE025405-6366-412B-818B-38307DE31C96Q37380847-E34BF71B-9FA1-46C4-ABB0-84E5BA6EB302Q37486259-D0BB1BC2-3B1C-463D-BFBF-97E8A94C3774Q37590874-DAACAC17-FA40-4E3F-BFBD-CCF10E44E437Q37696036-B774D32A-639D-4D54-ACAB-57BE2FAD8651Q37734908-1589656A-F058-4659-84E7-F7087A66FD7BQ37774392-7869E215-E0D2-45EF-939F-BDD47F8A474EQ38224605-3AA75D02-BEC3-4039-B5AD-E1D7A9C05FF4Q38584950-C13E8162-56F9-4108-8FF3-0CD09F51221CQ38725760-73214BDF-149E-479B-A4F9-6B4735342FA5Q38934305-5C64F2D5-2962-4CB3-AF9F-84A60F79FE05Q39520225-4E183EDB-D10F-44DB-8CF3-A0BAAE1A062AQ40027360-48B7D128-871F-44D3-8581-7BD1A88CC663Q40799982-06068753-9C8B-4A47-8E79-0896F9656D89
P2860
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
description
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im Juni 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/06/15)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/06/15)
@nl
наукова стаття, опублікована в червні 1995
@uk
مقالة علمية (نشرت في 15-6-1995)
@ar
name
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@ast
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@en
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@nl
type
label
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@ast
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@en
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@nl
prefLabel
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@ast
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@en
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@nl
P2093
P3181
P1433
P1476
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
@en
P2093
P304
P3181
P407
P577
1995-06-15T00:00:00Z